INTRODUCTION
Idiopathic granulomatous mastitis (IGM) is defi ned as a rare, infl ammatory, chronic and benign disease mimicking malignant hyperplasia of mammary glands. [1] [2] [3] [4] [5] Risk factors contributing to IGM incidence are not precisely clarifi ed; however, autoimmune and infectious diseases (such as Corynebacterium specious), contraceptive pills, hyperprolactinoma, trauma and alpha one antitrypsin defi ciency are oriented as some critical risk factors contributing IGM cases in the society. [1, [3] [4] [5] [6] [7] IGM is usually appeared as a unilateral, distinct and painful mass. Nonetheless, it is likely to appear as cutaneous lesion, nipple retraction, sinus formation, fi stula, abscess and lymphadenopathy. [1, 8] Sonography findings comprise hypo echoic lobulated mass diff erential diagnosis of IGM and malignancy is ambiguous. [9] To demonstrate mastectomy is a high risk approach while tumor malignancy is not approved. [3] Scientifi c fi ndings show augmented relapses of IGM, whereas implementation of numerous surgeries is associated with augmented probability of wound infection, sinus formation and other cosmetic issue. [4, 9] In addition, scientists suggest application of immunosuppressive components such as corticosteroids due to implication of autoimmune disorders as a causative factor of IGM. [5, 7] Antibiotic therapy is not widely analyzed in IGM as well as other chemotherapy approaches; nonetheless, Antibiotics are widely used in IGM cases, due to high probability of Corynebacterium infections. [8] In this study, the surgery strategy was compared with concurrent azithromycin and corticosteroid treatment in IGM patients. The medical group consisted of 20 consecutive patients, which was compared with a historical control treated through surgical approach. Surgical group comprised 39 patients who had operation of IGM (in their medical history) providing their treatment had been implemented more than 1 year (since the commencement of the research). IGM was confirmed through histopathological and bacteriological methods.
MATERIALS AND METHODS

This study was implemented as
In the medical group, questionnaires included demographic information like age, marital status, number of children, situation of lactation and also, baseline clinical data such as lymphadenopathy, pain, abscess, fever and number, side and size of lesions. Some data such as lymphadenopathy, abscess, fever (temperature >37.2°C), number, and side of lesions were collected by physical examinations, whereas the size of lesions was measured through sonography and the other information such as the pain was collected through interview. Treatment protocol consisted of concurrent administration of azithromycin (250 mg twice daily) and prednisolone (60 mg daily) for 2 weeks.
A erwards, prednisolone treatment was continued for 8 weeks (40 mg/day), then, it was tapered for 6 months. Patients were followed for recurrence of masses through physical examination for 12 months since initiation of treatment.
The surgical group consisted of patients who underwent partial mastectomy, as a conventional method, about more than a year before the study. We used medical documents of patients in order to gather information about age, marital status, number of children, situation of lactation, lymphadenopathy, pain, abscess, fever, number, side and size of lesions, and recurrence of mass. Indeed, relapse was evaluated for 12 months a er the surgery.
The data were analyzed by SPSS for Windows version 20 (SPSS Inc., Chicago, IL, USA). Fisher exact test, Mann-Whitney U-test, and Chi-square test were used to analyze data whenever appropriate. To compare the recurrence rate a er 12 months of the initiation of treatment in the two groups we used Chi-square test be jaye ghesmate neveshte shode ebarate zir neveshte gardad. In order to study the association of type of the treatment to the recurrence rate we used regression method to control factors contributing to relapse such as lacrimation, abscess, number of children, size and number of lesions.
RESULTS
A total of 59 women documented for IGM through biopsy technique were included in this study. 20 patients were treated through medical approaches in a clinical trial, whilst the effi cacy of surgical treatment was analyzed in 39 cases of IGMs. One patient treated through medical approach was excluded due to pregnancy situation and one individual in the respective medical trial was transferred to surgical one due to failure of treatment.
Mean of ages of people included in medical approach and surgical approach were 30.3 (standard deviation [SD] = 6.38) and 36.74 (SD = 13.51), respectively without signifi cant statistical diff erence (P = 0.154). Most of the women were of reproductive age (77.9%), though, there was no signifi cant diff erence in above mentioned groups for marital status (P = 0. 108). Median of child numbers was two and three in medical and surgical groups respectively (P = 0.001). Moreover, 80% in medical group and 97% in the surgical group had a history of lactation (P = 0.041).
Information elaborating numbers, side and size of the lesions are presented in Table 1 . No signifi cant diff erences were recognized in baseline variables showing lymphadenopathy, fever and pain, however, number of the abscess was signifi cantly higher in the surgical group [ Table 1 ].
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The rate of relapse in pharmaceutical treatment and surgical treatment was 6.2% and 82% respectively (P < 0.001). We used regression test due to the diff erence of factors contributing to relapse of the disease [ Table 2 ]. Table 2 shows the number of lesions can prognoses the probability of the relapse, (odds ratio = 24.67 confi dence interval [CI] = 2.2-269.3), whereas the methods of treatment did not contribute to its likelihood (odds ratio = 12.5 CI = 0.52-299).
DISCUSSION
This article makes a comparison between two diff erent therapeutic methods comprising surgical approach, and special pharmaceutical regimen, which include corticosteroid and azithromycin without surgical approach.
This study demonstrates that there is no significant diff erence in recurrence of the IGM between surgical and pharmaceutical approaches, whereas the la er treatment shows less side eff ects (such as wound infection, abscess formation, and other cosmetic problems) furthermore, the last proceeded option could illustrate enough effi cacy.
Hence, the pharmaceutical approach (without surgery) is strongly recommended; nonetheless, surgery could be suggested in the case of recurrent patients or lack of pharmaceutical effi cacy.
However, there is no defi nite treatment in the case of IGM, whilst variety of methods has been testifi ed in diff erent studies. For example, DeHertogh et al. in 1980 were the fi rst who investigated the effi cacy of diff erent treatments and they concluded that corticosteroid is an appropriate option for the treatment of the disease. [10] Furthermore, Sakurai et al. sought this pharmaceutical approach and they authenticated that corticosteroid could be effi cient in 87% of patients without any relapse. [11] The proceeded results were validated by Hisuing et al. while their research implied that low doses of corticosteroids were effi cient; though, more investigations in this fi eld were recommended by them. [12] Moreover, in 2010, it was authenticated that corticosteroids provide appropriate treatment, whereas fi rst option should be allocated to surgery in the case of relapse, fi stula, and abscess. [13] Nonetheless, there are some investigations providing diff erent results. For example, Boufe al et al. testifi ed diff erent approaches, which include tumorectomy plus antibiotic therapy with or without non-steroidal anti-inflammatory drugs in 16 patients, tumorectomy plus antibiotic therapy and corticosteroid in one individual, and fi nally corticosteroid plus antibiotic therapy in three individual. This research showed that combination of surgery and corticosteroid application were the most appropriate approach since corticosteroids could be recommended in order to avoid relapse of the disease. It is suggested that the diverse result of the la er study might be justifi ed by the diff erence of the samples in comparison with the present study. [14] IGM, most of the times, occurs unilaterally and its clinical manifestations are defi ned as fever, lymphadenopathy, breast mass ranging from 0.5 to 15 cm. [14, 15] All of the patients in our study had breast masses and most of them were occurred unilateral in le breast. However, three patients had bilateral breast masses with proceeded clinical signs.
This study demonstrated that the number of breast masses was the only factor, which was signifi cantly related to IGM relapse: The probability of IGM relapse increased 24 times per one increase in the mass numbers.
The limitation of our study was smallness of sample size due to the rare incidence of the disease.
CONCLUSION
This clinical trial demonstrated that pharmaceutical treatment has appropriate effi cacy in IGM treatment relapse 
